Sweating under polypharmacy with tramadol, amitriptyline and duloxetine?
Picksak, G.; Stichtenoth, D.O.; May, M.
Medizinische Monatsschrift für Pharmazeuten 36(5): 195-196
2013
ISSN/ISBN: 0342-9601 PMID: 23758030 Document Number: 666613
Document emailed within 1 workday
Related Documents
Farghaly, H.S.; Abd-Ellatief, R.B.; Moftah, M.Z.; Mostafa, M.G.; Khedr, E.M.; Kotb, H.I. 2014: The effects of dexmedetomidine alone and in combination with tramadol or amitriptyline in a neuropathic pain model Pain Physician 17(2): 187-195Lepri, A.; Sia, S.; Catinelli, S.; Casali, R.; Novelli, G. 2006: Patient-controlled analgesia with tramadol versus tramadol plus ketorolac Minerva Anestesiologica 72(1-2): 59-67
Houck, J. 1970: Combined therapy in anxiety-depressive syndromes. II. Comparative effects of amitriptyline and limbitrol (chlordiazepoxide-amitriptyline) Diseases of the Nervous System 31(6): 421-426
Casacchia, M.; Cerbo, R.; Corona, R.; Boni, B. 1981: Double-blind study of the effects of amitriptyline and of a combination of amitriptyline and lithium on patients with chronic primary headache Rivista di Neurologia 51(2): 114-123
Striebel, H.W.; Hackenberger, J. 1992: A comparison of a tramadol/metamizole infusion with the combination tramadol infusion plus ibuprofen suppositories for postoperative pain management following hysterectomy Der Anaesthesist 41(6): 354-360
Chong, S.-A.; Ravichandran, N.; Poon, L.-Y.; Soo, K.-L.; Verma, S. 2006: Reducing polypharmacy through the introduction of a treatment algorithm: use of a treatment algorithm on the impact on polypharmacy Annals of the Academy of Medicine Singapore 35(7): 457-460
Pfaffenrath, V.; Diener, H.C.; Isler, H.; Meyer, C.; Scholz, E.; Taneri, Z.; Wessely, P.; Zaiser-Kaschel, H.; Haase, W.; Fischer, W. 1993: Effectiveness and tolerance of amitriptyline oxide in chronic tension headache--a multicenter double-blind study versus amitriptyline versus placebo Der Nervenarzt 64(2): 114-120
Pitsikas, N. 2000: Duloxetine Eli Lilly and Co Current Opinion in Investigational Drugs 1(1): 116-121
Pitchot, W. 2006: Medication of the month. Duloxetine (Cymbalta) Revue Medicale de Liege 61(11): 787-790
Mermi, O.; Atmaca, M. 2016: Duloxetine-Induced Hypertension: A Case Report Turk Psikiyatri Dergisi 27(1): 67-69
2005: Duloxetine (Cymbalta) for diabetic neuropathic pain Medical Letter on Drugs and Therapeutics 47(1215-1216): 67-68
Leo, R.J. 2003: A word of caution about the implied role for duloxetine in pain management Journal of Clinical Psychiatry 64(10): 1270
García Martín, Iés.; Miranda Vicario, E.M.; Soutullo, César.A. 2012: Duloxetine in the treatment of adolescents with somatoform disorders: a report of two cases Actas Espanolas de Psiquiatria 40(3): 165-168
Anand, K.S.; Dhikav, V.; Prasad, A.; Shewtengna 2011: Efficacy, safety and tolerability of duloxetine in idiopathic trigeminal neuralgia Journal of the Indian Medical Association 109(4): 264-266
Sheehy, T.W. 1991: Diabetic gustatory sweating American Journal of Gastroenterology 86(10): 1514-1517
Bailey, R.K.; Mallinckrodt, C.H.; Wohlreich, M.M.; Watkin, J.G.; Plewes, J.M. 2006: Duloxetine in the treatment of major depressive disorder: comparisons of safety and efficacy Journal of the National Medical Association 98(3): 437-447
Ryan, F. 1987: Polytherapy not polypharmacy Medical Journal of Australia 147(6): 316
Leppik, I.E. 2000: Monotherapy and polypharmacy Neurology 55(11 Suppl. 3): S25-S29
Shepherd, M. 1998: The risks of polypharmacy Nursing Times 94(32): 60-62
Shakib, S. 2002: Problems of polypharmacy Australian Family Physician 31(2): 125-128